C4 Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.About CCCC
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.
CEOAndrew J. Hirsch
CEOAndrew J. Hirsch
Employees110
Employees110
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2015
Founded2015
Employees110
Employees110
CCCC Key Statistics
Market cap145.88M
Market cap145.88M
Price-Earnings ratio-1.33
Price-Earnings ratio-1.33
Dividend yield—
Dividend yield—
Average volume998.76K
Average volume998.76K
High today$2.07
High today$2.07
Low today$1.97
Low today$1.97
Open price$2.05
Open price$2.05
Volume112.17K
Volume112.17K
52 Week high$10.82
52 Week high$10.82
52 Week low$1.95
52 Week low$1.95
Analyst ratings
60%
of 10 ratingsBuy
60%
Hold
40%
Sell
0%